‘Concerned’ FDA staff inquire about atypical meetings and workforce issues
Key Takeaways FDA leaders are actively working to restore normal operations after recent disruptions. Employees have expressed concerns over staffing, funding for research, and the shift in meeting protocols. The FDA is committed to retaining staff and filling vacant positions while encouraging employee feedback. Navigating Change at the FDA: What’s Happening Inside? The FDA is …








